Condition: Solid Organ Transplantation · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).
This description comes directly from the study's public registry record.
Marco Masetti, MD · 0512143725 · scompenso.trapiantocuore@aosp.bo.it
Always discuss trial participation with your own doctor first.
| IRCCS - Azienda ospedaliero-universitaria di Bologna | Bologna, Italy | Recruiting |
| IRCCS - Azienda ospedaliero-universitaria di Bologna | Bologna, Italy | Recruiting |
| IRCCS - Azienda ospedaliero-universitaria di Bologna | Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06774339